Christopher Molineaux - Net Worth and Insider Trading

Christopher Molineaux Net Worth

The estimated net worth of Christopher Molineaux is at least $757 dollars as of 2024-05-04. Christopher Molineaux is the SR. VP, DEVELOPMENT of Calithera Biosciences Inc and owns about 37,859 shares of Calithera Biosciences Inc (CALA) stock worth over $757. Details can be seen in Christopher Molineaux's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Molineaux has not made any transactions after 2021-11-10 and currently still holds the listed stock(s).

Transaction Summary of Christopher Molineaux

To

Christopher Molineaux Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Molineaux owns 1 companies in total, including Calithera Biosciences Inc (CALA) .

Click here to see the complete history of Christopher Molineaux’s form 4 insider trades.

Insider Ownership Summary of Christopher Molineaux

Ticker Comapny Transaction Date Type of Owner
CALA Calithera Biosciences Inc 2021-11-10 SR. VP & DEVELOPMENT

Christopher Molineaux Latest Holdings Summary

Christopher Molineaux currently owns a total of 1 stock. Christopher Molineaux owns 37,859 shares of Calithera Biosciences Inc (CALA) as of November 10, 2021, with a value of $757.

Latest Holdings of Christopher Molineaux

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CALA Calithera Biosciences Inc 2021-11-10 37,859 0.02 757

Holding Weightings of Christopher Molineaux


Christopher Molineaux Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Molineaux has made a total of 2 transactions in Calithera Biosciences Inc (CALA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Calithera Biosciences Inc is the acquisition of 5,000 shares on November 10, 2021, which cost Christopher Molineaux around $85,000.

Insider Trading History of Christopher Molineaux

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Molineaux Trading Performance

GuruFocus tracks the stock performance after each of Christopher Molineaux's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Molineaux is -24.58%. GuruFocus also compares Christopher Molineaux's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Molineaux within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Molineaux's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Molineaux

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.91
Relative Return to S&P 500(%) -1.28

Christopher Molineaux Ownership Network

Ownership Network List of Christopher Molineaux

No Data

Ownership Network Relation of Christopher Molineaux


Christopher Molineaux Owned Company Details

What does Calithera Biosciences Inc do?

Who are the key executives at Calithera Biosciences Inc?

Christopher Molineaux is the SR. VP & DEVELOPMENT of Calithera Biosciences Inc. Other key executives at Calithera Biosciences Inc include director & 10 percent owner Deepika Pakianathan , 10 percent owner Takeda Ventures, Inc. , and SR. VP & CLINICAL DEVELOPMENT Keith Orford .

Calithera Biosciences Inc (CALA) Insider Trades Summary

Over the past 18 months, Christopher Molineaux made no insider transaction in Calithera Biosciences Inc (CALA). Other recent insider transactions involving Calithera Biosciences Inc (CALA) include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Calithera Biosciences Inc Insider Transactions

No Available Data

Christopher Molineaux Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Molineaux. You might contact Christopher Molineaux via mailing address: Calithera Biosciences, 343 Oyster Point, Suite 200, South San Francisco Ca 94080.

Discussions on Christopher Molineaux

No discussions yet.